Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2020

Significance of transcriptionally-active high-risk human papillomavirus in sinonasal squamous cell carcinoma: Case series and a meta-analysis
Authors: M. ŠVAJDLER, J. NĚMCOVA, P. DUBINSKÝ, A. METELKOVA, P. ŠVAJDLER, Ľ. STRAKA, R. SAKAŘ, O. DAUM, M. MICHAL, A. SKÁLOVÁ, R. MEZENCEV
Neoplasma Vol.67, No.6, p.1456–1463, 2020
doi:10.4149/neo_2020_200330N332
Price: free access
[View Abstract]


Adjuvant radiotherapy treatment for soft tissue sarcoma of extremities and trunk. A retrospective mono-institutional analysis
Authors: R. SPOTO, A. VAVASSORI, S. DICUONZO, M. PEPA, S. VOLPE, O. ALESSANDRO, S. GANDINI, B. DI VENOSA, E. MIGLIETTA, C. FODOR, G. M. ORSOLINI, P. PRESTIANNI, F. CATTANI, S. COMI, R. LAZZARI, G. RENNE, T. DE PAS, R. ORECCHIA, E. PENNACCHIOLI, B. A. JERECZEK-FOSSA
Neoplasma Vol.67, No.6, p.1447–1455, 2020
doi:10.4149/neo_2020_200325N305
Price: free access
[View Abstract]


Association of quantitative MRI-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma
Authors: C. GIANNITTO, G. MARVASO, F. BOTTA, S. RAIMONDI, D. ALTERIO, D. CIARDO, S. VOLPE, F. DE PIANO, E. ANCONA, M. TAGLIABUE, D. ORIGGI, S. CHIOCCA, F. A. MAFFINI, M. ANSARIN, V. BAGNARDI, F. CATTANI, F. NOLÈ, L. PREDA, R. ORECCHIA, E. CASSANO, M. CREMONESI, A. STARZYŃSKA, M. BELLOMI, B. A. JERECZEK-FOSSA
Neoplasma Vol.67, No.6, p.1437–1446, 2020
doi:10.4149/neo_2020_200310N249
Price: free access
[View Abstract]


The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma
Authors: A. ARMATYS, A. WIECZORKIEWICZ-KABUT, M. PANZ-KLAPUCH, A. KOCLEGA, A. J. KOPINSKA, D. KATA, K. WOZNICZKA, G. HELBIG
Neoplasma Vol.67, No.6, p.1431–1436, 2020
doi:10.4149/neo_2020_200303N224
Price: free access
[View Abstract]


Insights from the Greek experience of the use of Blinatumomab in pediatric relapsed and refractory acute lymphoblastic leukemia patients
Authors: Μ. ΑMPATZIDOU, A. KATTAMIS, M. BAKA, G. PATERAKIS, T. ANASTASIOU, M. TZANOUDAKI, A. KAISARI, G. AVGERINOU, D. DOGANIS, V. PAPADAKIS, V. KITRA, S. POLYCHRONOPOULOU
Neoplasma Vol.67, No.6, p.1424–1430, 2020
doi:10.4149/neo_2020_200128N93
Price: free access
[View Abstract]


Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis
Authors: D. COMANDINI, M. GRASSI, A. PRELAJ, V. MARTELLI, A. DAMIANI, G. DAMIANO, S. E. REBUZZI
Neoplasma Vol.67, No.6, p.1416–1423, 2020
doi:10.4149/neo_2020_200301N212
Price: free access
[View Abstract]


Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer.
Authors: W.P. LI, T. ZHU, M.X. HU, M. YANG, F. JI, H. F. GAO, C. Q. YANG, L. L. ZHANG, M. Y. CHENG, F. P. XU, K. WANG
Neoplasma Vol.67, No.6, p.1409–1415, 2020
doi:10.4149/neo_2020_200130N96
Price: free access
[View Abstract]


Objective response of first-line chemotherapy of triple-negative breast cancer translates into survival benefit: an analysis in an independent, prospective clinical trial and a real-world setting
Authors: T. LI, Y. H. ZHU, J. ZHANG, B. Y. WANG, S. ZHANG, L. P. WANG, J. CAO, Z. H. TAO, J. XIE, X. C. HU
Neoplasma Vol.67, No.6, p.1400–1408, 2020
doi:10.4149/neo_2020_200225N182
Price: free access
[View Abstract]


Etiology of candidemia in patients with solid tumors - 7 years of experience of one oncology center
Authors: M. SZYMANKIEWICZ, T. NOWIKIEWICZ
Neoplasma Vol.67, No.6, p.1391–1399, 2020
doi:10.4149/neo_2020_200204N105
Price: free access
[View Abstract]


Third-line treatment for metastatic colorectal cancer: anlotinib is superior to chemotherapy and similar to fruquintinib or regorafenib
Authors: Y. CHENG, F. C. DU, F. Q. FANG, Z. J. DUAN, W. LEI, K. G. SHI
Neoplasma Vol.67, No.6, p.1384–1390, 2020
doi:10.4149/neo_2020_191125N1212
Price: free access
[View Abstract]


Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database
Authors: I. KOLAROVA, J. VANASEK, M. DOLEZEL, J. STUK, A. HLAVKA, L. DUSEK, B. MELICHAR, T. BÜCHLE, A. RYSKA, J. PRAUSOVA, K. PETRAKOVA, P. TESAROVA, J. PETERA, M. VOSMIK, K. HORACKOVA, J. JARKOVSKY
Neoplasma Vol.67, No.6, p.1373–1383, 2020
doi:10.4149/neo_2020_191023N1080
Price: free access
[View Abstract]


Quantitative analysis of 2-hydroxyglutarate as a controversial oncometabolite in malignant gliomas.
Authors: P. BYSTRICKÝ, I. KAŠUBOVÁ, R. RICHTEROVÁ, Z. LASABOVÁ, B. KOLAROVSZKI
Neoplasma Vol.67, No.6, p.1367–1372, 2020
doi:10.4149/neo_2020_200302N216
Price: free access
[View Abstract]


The loss of PTEN expression and microsatellite stability (MSS) were predictors of unfavorable prognosis in gastric cancer (GC)
Authors: J. P. FAN, J. QIAN, Y. J. ZHAO
Neoplasma Vol.67, No.6, p.1359–1366, 2020
doi:10.4149/neo_2020_200422N427
Price: free access
[View Abstract]


Novel spectroscopic biomarkers are applicable in non-invasive early detection and staging classification of colorectal cancer
Authors: M. MISKOVICOVA, V. FRYBA, L. PETRUZELKA, V. SETNICKA, A. SYNYTSYA, M. TATARKOVIC, J. ULRYCH, M. VOCKA
Neoplasma Vol.67, No.6, p.1349–1358, 2020
doi:10.4149/neo_2020_200506N494
Price: free access
[View Abstract]


Identification of large deletions in the APC gene in Russian patients with familial adenomatous polyposis
Authors: A. S. TSUKANOV, V. V. ZABNENKOVA, V. P. SHUBIN, D. Y. PIKUNOV, T. A. SAVELYEVA, A. M. KUZMINOV, S. A. FROLOV, A. V. POLYAKOV, Y. A. SHELYGIN
Neoplasma Vol.67, No.6, p.1343–1348, 2020
doi:10.4149/neo_2020_191230N1351
Price: free access
[View Abstract]


Neuropilin1, a novel independent prognostic factor and therapeutic target in triple-negative breast cancer
Authors: H. WANG, Y. N. ZHANG, D. Q. XU, J. G. HUANG, D. LV, X. Y. SHI, J. Y. LIU, H. W. REN, Z. X. HAN
Neoplasma Vol.67, No.6, p.1335–1342, 2020
doi:10.4149/neo_2020_191127N1223
Price: free access
[View Abstract]


Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer
Authors: J. GATEK, V. PETRU, P. KOSAC, M. RATAJSKY, J. DUBEN, B. DUDESEK, P. JANCIK, M. ZABOJNIKOVA, J. KATRUSAK, P. OPELOVA, L. PODRAZSKA, P. VAZAN, P. KUDLOVA, P. HOLIK, B. MELICHAR, D. VRANA
Neoplasma Vol.67, No.6, p.1329–1334, 2020
doi:10.4149/neo_2020_191228N1344
Price: free access
[View Abstract]


Correlation of survival length after pancreaticoduodenectomy for pancreatic head adenocarcinoma depending on tumor characteristics detected by means of computed tomography and resection margins status
Authors: V. PROCHAZKA, J. HLAVSA, L. KUNOVSKY, M. FARKASOVA, M. POTRUSIL, T. ANDRASINA, A. LITAVCOVA, J. MAZANEC, J. DOLINA, L. OSTRIZKOVA, M. EID, P. KOVALCIKOVA, T. PAVLIK, Z. KALA
Neoplasma Vol.67, No.6, p.1319–1328, 2020
doi:10.4149/neo_2020_190923N955
Price: free access
[View Abstract]


Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer
Authors: W. LI, Y. DONG, K. J. WANG, Z. DENG, W. ZHANG, H. F. SHEN
Neoplasma Vol.67, No.6, p.1314–1318, 2020
doi:10.4149/neo_2020_191130N1234
Price: free access
[View Abstract]


Lamin B1 deficiency promotes malignancy and predicts poor prognosis in gastric cancer
Authors: Z. Y. YU, X. Y. JIANG, R. R. ZHAO, C. J. LUO, Y. X. REN, Z. J. MA, H. L. YE, W. G. SHI, C. WANG, Z. Y JIAO
Neoplasma Vol.67, No.6, p.1303–1313, 2020
doi:10.4149/neo_2020_200109N33
Price: free access
[View Abstract]





Display #  
Results 1 - 20 of 159

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.